Patients with chronic kidney disease under hemodialysis... Chronic kidney disease, stage 5.
Conditions
Interventions
Intervention: Determining patient's dry weight with lower limb bioimpedance spectroscopy. Lower limb bioimpedance spectroscopy will be done at supine position in the time of dialysis. Calf resistance
Diagnosis
Sponsors
Vice chancellor for research of Tehran University of Medical Sciences.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients older than 18 years old who have the history of dialysis for more than 3 months. Exclusion criteria: Psychiatric diseases; pregnancy; breastfeeding; stage 4 of congestive heart failure; positive history of myocardial infarction or stroke in past 6 months; having cardiac pacemaker or implant; having knee or hip implant; having deep venous thrombosis or lymph edema in lower limb.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dry weight. Timepoint: During at frist session of hemodialysis, at third month after patient reaches to her or his gaol dry weight, at sixth month after patient reaches to her or his gaol dry weight. Method of measurement: Lower limb bioimpedance spectroscopy.;Pro b-type Natriuretic Peptide. Timepoint: At baesline and at the end of study (when patient entry to our study and six month later when the study end). Method of measurement: blood analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before and after dialysis. Method of measurement: Physical examination with sphengomanometer.;Sodium. Timepoint: Every month during study. Method of measurement: blood analysis.;Potassium. Timepoint: Every month during study. Method of measurement: blood analysis.;Adequacy of dialysis. Timepoint: Every month during study. Method of measurement: With measurement of blood urea before and after dialysis and approciate formula for calculation of adequacy of dialysis (Kt/v formula).;Albumin. Timepoint: Every month during study. Method of measurement: blood analysis.;Blood lipids (triglycerides, cholesterol). Timepoint: Every month during study. Method of measurement: blood analysis.;Complete blood count. Timepoint: Every month during study. Method of measurement: blood analysis.;Fasting blood glucose. Timepoint: Every month during study. Method of measurement: blood analysis.;Creatinine. Timepoint: Every month during study. Method of measurement: blood analysis.;Urea. Timepoint: Every month during study. Method of measurement: blood analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohamadtaghi Najafi.
Imam hospital.
Outcome results
None listed